Clinical Trial

Regulation of Platelet Function in Older Patients With Atrial Fibrillation

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to learn about the effects of antiplatelet drugs on patients over the age of 80 with atrial fibrillation. The main question it aims to answer is: -Is platelet reactivity effectively controlled in patients over the age of 80 diagnosed with atrial fibrillation following the Watchman procedure.
Trial Details
NCT Number NCT07724301
Lead Sponsor University of Michigan
Conditions Atrial Fibrillation, Thrombotic Risk
Enrollment 50 participants
Start Date 2026-08
Primary Completion 2028-08 (estimated)
Study Completion 2028-08 (estimated)
Updated on ClinicalTrials.gov 2026-07-24